Cargando…
Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
In 2017 the World Health Organization revised the criteria for classification of pancreatic neuroendocrine neoplasms (pNENs) after a consensus conference at the International Agency for Research on Cancer. The major change in the new classification was to subclassify the original G3 group into well-...
Autores principales: | Zhang, Ming-Yi, He, Du, Zhang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428799/ https://www.ncbi.nlm.nih.gov/pubmed/32864039 http://dx.doi.org/10.4251/wjgo.v12.i7.705 |
Ejemplares similares
-
Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
por: Ro, Cynthia, et al.
Publicado: (2013) -
Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target
por: Kelgiorgi, Dionysia, et al.
Publicado: (2017) -
Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future
por: Ohmoto, Akihiro, et al.
Publicado: (2017) -
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
por: Simon, Tincy, et al.
Publicado: (2022) -
Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)